{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T23:10:21Z","timestamp":1759965021845,"version":"build-2065373602"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,8]]},"DOI":"10.7759\/cureus.94150","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:33:01Z","timestamp":1759962781000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Treatment of Pericardial Drainage and Platinum-Based Chemotherapy in a Case of BRCA-Positive Serous Peritoneal Carcinoma Complicated by Cardiac Tamponade"],"prefix":"10.7759","author":[{"given":"Akinori","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rika","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-63. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0771","article-title":"Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004","volume":"18","author":"Goodman MT","year":"2009","unstructured":"Goodman MT, Shvetsov YB. Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004. Cancer Epidemiol Biomarkers Prev. 2009, 18:132-9. 10.1158\/1055-9965.EPI-08-0771","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.07.014","article-title":"Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO","volume":"66","author":"Klar M","year":"2016","unstructured":"Klar M, Hasenburg A, Hasanov M, et al.. Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO. Eur J Cancer. 2016, 66:114-24. 10.1016\/j.ejca.2016.07.014","journal-title":"Eur J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2020.100621","article-title":"Cytology positive pericardial effusion causing tamponade in patients with high grade serous carcinoma of the ovary","volume":"33","author":"Kooy J","year":"2020","unstructured":"Kooy J, Findley R, Nelson G, Chu P. Cytology positive pericardial effusion causing tamponade in patients with high grade serous carcinoma of the ovary. Gynecol Oncol Rep. 2020, 33:100621. 10.1016\/j.gore.2020.100621","journal-title":"Gynecol Oncol Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2015.04.024","article-title":"Malignant pericardial effusion in ovarian malignancy: a treatable oncologic emergency","volume":"49","author":"Perri T","year":"2015","unstructured":"Perri T, Lantsberg D, Ben-Baruch G, Beiner ME, Jakobson-Setton A, Korach J. Malignant pericardial effusion in ovarian malignancy: a treatable oncologic emergency. J Emerg Med. 2015, 49:281-3. 10.1016\/j.jemermed.2015.04.024","journal-title":"J Emerg Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"The Cancer Genome Atlas Research Network","year":"2011","unstructured":"The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011, 474:609-15. 10.1038\/nature10166","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma","volume":"2","author":"Norquist BM","year":"2016","unstructured":"Norquist BM, Harrell MI, Brady MF, et al.. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2016, 2:482-90. 10.1001\/jamaoncol.2015.5495","journal-title":"JAMA Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2287","article-title":"Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas","volume":"20","author":"Pennington KP","year":"2014","unstructured":"Pennington KP, Walsh T, Harrell MI, et al.. Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. Clin Cancer Res. 2014, 20:764-75. 10.1158\/1078-0432.CCR-13-2287","journal-title":"Clin Cancer Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2015.21","article-title":"BRCAness revisited","volume":"16","author":"Lord CJ","year":"2016","unstructured":"Lord CJ, Ashworth A. BRCAness revisited. Nat Rev Cancer. 2016, 16:110-20. 10.1038\/nrc.2015.21","journal-title":"Nat Rev Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911361","article-title":"Olaparib plus bevacizumab as first-line maintenance in ovarian cancer","volume":"381","author":"Ray-Coquard I","year":"2019","unstructured":"Ray-Coquard I, Pautier P, Pignata S, et al.. Olaparib plus bevacizumab as first-line maintenance in ovarian cancer. N Engl J Med. 2019, 381:2416-28. 10.1056\/NEJMoa1911361","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951015)76:8<1377::aid-cncr2820760813>3.0.co;2-m","article-title":"Malignancy-related pericardial effusion. 127 cases from the Roswell Park Cancer Institute","volume":"76","author":"Wilkes JD","year":"1995","unstructured":"Wilkes JD, Fidias P, Vaickus L, et al.. Malignancy-related pericardial effusion. 127 cases from the Roswell Park Cancer Institute. Cancer. 1995, 76:1377-87. 10.1002\/1097-0142(19951015)76:8&lt;1377::aid-cncr2820760813&gt;3.0.co;2-m","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27409","article-title":"Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer","volume":"118","author":"Doebele RC","year":"2012","unstructured":"Doebele RC, Lu X, Sumey C, et al.. Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer. Cancer. 2012, 118:4502-11. 10.1002\/cncr.27409","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000199556.69588.8e","article-title":"Large symptomatic pericardial effusion as the presentation of unrecognized cancer: a study in 173 consecutive patients undergoing pericardiocentesis","volume":"85","author":"Ben-Horin S","year":"2006","unstructured":"Ben-Horin S, Bank I, Guetta V, Livneh A. Large symptomatic pericardial effusion as the presentation of unrecognized cancer: a study in 173 consecutive patients undergoing pericardiocentesis. Medicine (Baltimore). 2006, 85:49-53. 10.1097\/01.md.0000199556.69588.8e","journal-title":"Medicine (Baltimore)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19800401)45:7<1697::aid-cncr2820450730>3.0.co;2-j","article-title":"Cardiac tamponade as a presentation of extracardiac malignancy","volume":"45","author":"Fraser RS","year":"1980","unstructured":"Fraser RS, Viloria JB, Wang NS. Cardiac tamponade as a presentation of extracardiac malignancy. Cancer. 1980, 45:1697-704. 10.1002\/1097-0142(19800401)45:7&lt;1697::aid-cncr2820450730&gt;3.0.co;2-j","journal-title":"Cancer"},{"key":"ref15","article-title":"Management of Malignant Pericardial Effusion","volume":"5","author":"Petrofsky M","year":"2014","unstructured":"Petrofsky M. Management of Malignant Pericardial Effusion. J Adv Pract Oncol. 2014, 5:281-9.","journal-title":"J Adv Pract Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2006.00584.x","article-title":"Malignant pericardial effusion with cardiac tamponade in a patient with metastatic vaginal adenocarcinoma","volume":"16","author":"Nagarsheth NP","year":"2006","unstructured":"Nagarsheth NP, Harrison M, Kalir T, Rahaman J. Malignant pericardial effusion with cardiac tamponade in a patient with metastatic vaginal adenocarcinoma. Int J Gynecol Cancer. 2006, 16:1458-61. 10.1111\/j.1525-1438.2006.00584.x","journal-title":"Int J Gynecol Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2017.00079","article-title":"Echocardiographic evaluation of pericardial effusion and cardiac tamponade","volume":"5","author":"P\u00e9rez-Casares A","year":"2017","unstructured":"P\u00e9rez-Casares A, Cesar S, Brunet-Garcia L, Sanchez-de-Toledo J. Echocardiographic evaluation of pericardial effusion and cardiac tamponade. Front Pediatr. 2017, 5:79. 10.3389\/fped.2017.00079","journal-title":"Front Pediatr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1378\/chest.112.4_supplement.291s","article-title":"Malignant effusive disease of the pleura and pericardium","volume":"112","author":"DeCamp MM Jr","year":"1997","unstructured":"DeCamp MM Jr, Mentzer SJ, Swanson SJ, Sugarbaker DJ. Malignant effusive disease of the pleura and pericardium. Chest. 1997, 112:291S-5S. 10.1378\/chest.112.4_supplement.291s","journal-title":"Chest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/386655-successful-treatment-of-pericardial-drainage-and-platinum-based-chemotherapy-in-a-case-of-brca-positive-serous-peritoneal-carcinoma-complicated-by-cardiac-tamponade","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:33:01Z","timestamp":1759962781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/386655-successful-treatment-of-pericardial-drainage-and-platinum-based-chemotherapy-in-a-case-of-brca-positive-serous-peritoneal-carcinoma-complicated-by-cardiac-tamponade"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.94150","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,8]]}}}